Human malignant B cells expressed lower levels of IL-1R8 mRNA than normal B cells, and accordingly, in the well-established transgenic mouse model of CLL (TCL1), CD19+ B cells expressed lower levels of IL-1R8 mRNA transcript, compared with controls (107–110). This evidence concerns the gene SIGIRR and B-cell chronic lymphocytic leukemia.